MATTHEW M LOAR Insider Trading $MATN Oncotelic Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW M LOAR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW M LOAR. MATTHEW M LOAR is CFO in GENELABS TECHNOLOGIES INC /CA ($GNLB) and Chief Financial Officer in OXIGENE INC ($OXGN).
MATTHEW M LOAR in Oncotelic Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW M LOAR: Chief Financial Officer
Holdings: 300,000 shares
Latest Transaction: Jun 22 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MATTHEW M LOAR in Oncotelic Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
| Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.22 | 250,000 | 55,000 | 250,000 | |
| Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
| Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
| Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Buy | P | 0.00 | 250,000 | 0 | 300,000 | 50 K to 300 K (+500.00 %) |
| Jan 13 2017 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.38 | 350,000 | 131,250 | 350,000 | |
| Mar 23 2016 | OXGN | OXIGENE INC | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.73 | 262,500 | 191,021 | 262,500 | |
| Jul 20 2015 | OXGN | OXIGENE INC | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 1.37 | 150,000 | 205,500 | 150,000 |
Page: 1